Related Experiment Videos
Fibronectin, cartilage, and osteoarthritis
1Service de Rhumatologie, Hôpital Henri-Mondor, Creteil, France.
Seminars in Arthritis and Rheumatism
|April 1, 1993
Summary
In osteoarthritis (OA), fibronectin levels rise in cartilage due to increased chondrocyte synthesis. This elevated fibronectin may drive cartilage degeneration or attempt repair, with its role still unclear.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Fibronectin is a glycoprotein in normal cartilage extracellular matrix, involved in cell-matrix adhesion and matrix organization.
- Osteoarthritis (OA) is characterized by increased fibronectin synthesis and accumulation in the cartilage matrix.
- OA cartilage contains fibronectin isoforms more susceptible to proteolytic cleavage than normal cartilage.
Purpose of the Study:
- To investigate the role of increased fibronectin synthesis in osteoarthritis (OA).
- To understand whether elevated fibronectin in OA contributes to cartilage repair or degeneration.
Main Methods:
- Analysis of fibronectin content and isoforms in normal vs. OA cartilage.
- Assessment of chondrocyte synthesis and extracellular matrix accumulation of fibronectin.
- Evaluation of fibronectin's functional consequences on chondrocytes and matrix components.
Main Results:
- Fibronectin content is significantly increased in OA cartilage due to enhanced chondrocyte production.
- OA-associated fibronectins exhibit increased sensitivity to proteolytic degradation.
- Elevated fibronectin may alter chondrocyte phenotype, collagen synthesis, and protease activity.
Conclusions:
- Increased fibronectin in OA cartilage has multifaceted consequences, including potential changes in chondrocyte function and matrix degradation.
- The precise role of early fibronectin upregulation in OA—whether reparative or deleterious—remains to be elucidated.